51 filings
6-K
NYXH
Nyxoah SA
15 Apr 24
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
4:05pm
6-K
NYXH
Nyxoah SA
19 Mar 24
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
4:57pm
6-K
NYXH
Nyxoah SA
5 Mar 24
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
4:13pm
6-K
NYXH
Nyxoah SA
17 Jan 24
Nyxoah Announces 2024 Strategic Priorities
4:12pm
6-K
NYXH
Nyxoah SA
9 Jan 24
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023
5:00pm
6-K
m137dw
11 Dec 23
Current report (foreign)
4:05pm
6-K
lv4jk9eng ix7aqql
8 Nov 23
Nyxoah Reports Third Quarter 2023 Financial and Operating Results
4:24pm
6-K
pei4lmnajbgx
29 Sep 23
Nyxoah Announces Partnership with ResMed in Germany
4:05pm
6-K
vc0yl 3cw
8 Aug 23
Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results
5:56pm
6-K
wlfubn92i7ooa7
28 Jul 23
Information on the total number of voting rights and shares
3:59pm
6-K
rojjd b5e
16 May 23
Nyxoah Reports First Quarter 2023 Financial and Operating Results
4:17pm
6-K
2jmb1l ov7tyd
15 May 23
Current report (foreign)
4:07pm
6-K
gxj7juhx7b2rebcv1b
11 May 23
Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer
4:05pm
6-K
rey lsbhlm
20 Apr 23
Current report (foreign)
5:03pm
6-K
wbxpgeeyyik
13 Apr 23
Current report (foreign)
4:09pm
6-K
mgm k2w6s7byd
27 Mar 23
Nyxoah Raises $3 Million from an At-the-Market Equity Offering
5:00pm
6-K
w8xgper6 z5pz
23 Mar 23
Nyxoah Announces a $15 Million Private Placement Financing
4:28pm
6-K
okv0 kwjf8
22 Mar 23
Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
4:14pm
6-K
90ucojp
15 Mar 23
Current report (foreign)
4:37pm
6-K
a364 638s
6 Mar 23
Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones
4:57pm